atrasentan has been researched along with Coronary Heart Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for atrasentan and Coronary Heart Disease
| Article | Year |
|---|---|
ABT 627. A 147627, ABT 147627.
Topics: Adenocarcinoma; Animals; Atrasentan; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Coronary Disease; Drugs, Investigational; Endothelin Receptor Antagonists; Humans; Male; Prostatic Neoplasms; Pyrrolidines | 1999 |